. "4. Comparison of Disease Burdens." New Vaccine Development: Establishing Priorities: Volume II, Diseases of Importance in Developing Countries. Washington, DC: The National Academies Press, 1986.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development: Establishing Priorities, Volume II, Diseases of Importance in Developing Countries
15–59 Years
60 Years and Over
Cases
Duration (days)
Infant Mortality Equivalence Value
Subtotal
Cases
Duration (days)
Infant Mortality Equivalence Value
Subtotal
Subtotal by Category
8,750
0
50,000
0
0
2,256,561
7
5,650
2,796
149,378
7
25,000
42
3,133
1,221,794
14
2,000
8,553
206,277
14
5,000
578
10,342
n.a.
30
0
n.a.
550
0
0
n.a.
2.75
0
n.a.
23.125
0
0
n.a.
0.309
0
n.a.
5
0
0
n.a.
16.5
0
n.a.
300
0
0
5,146
n.a.
0.4
12,865
8,005
n.a.
5
1,601
16,754
24,213
2,220
30,229
generally not practical to determine the extent of the error. Therefore, raw data on reported disease incidence were rarely used as a sole basis for disease estimates.)
Conditions affecting disease incidence are not uniform. Therefore, the exceptionally broad scope of the attempted estimates and the occasional need to extrapolate data from very few countries or studies to the entire developing world led to numerical estimates of uncertain validity.
For certain conditions, the estimates (both absolute numbers
